Cardiac function and heart failure

Identifieur interne : 002265 ( Istex/Corpus ); précédent : 002264; suivant : 002266

---

Cardiac function and heart failure

Auteurs :

Source :

• Journal of the American College of Cardiology [ 0735-1097 ] ; 2001.

RBID : ISTEX:945CBB5E1AA287E2E692FEDCFEFB96C006306D15

English descriptors

• Teeft :
  • Abnormal, Abnormal heart rate recovery, Abnormality, Acei, Acetylcholine, Actc, Actin, Adenosine, Adrenergic, Adventist, Agonist, Aldehyde, Aldosterone, Allele, Allograft, Amiodarone, Amyloid, Amyloidosis, Angina, Angiographic, Angiography, Angiotensin, Anker, Annular, Annulus, Anova, Antioxidant, Antioxidant vitamins, Antithrombin, Aortic, Apical, Apoptosis, Aprotinin, Arrhythmia, Arteriopathy, Assay, Asymptomatic, Atherosclerosis, Atrial, Atrial fibrillation, Atrium, Attenuated, Basal, Baseline, Baseline characteristics, Beneficial effects, Beta, Beta blocker, Beta blockers, Bisoprolol, Biventricular, Blocker, Blood pressure, Bmp4, Body weight, Brain natriuretic peptide, Bucindolol, Cabg, Canada background, Candesartan, Captopril, Cardiac, Cardiac death, Cardiac disease, Cardiac dysfunction, Cardiac events, Cardiac function, Cardiac index, Cardiac output, Cardiac rehabilitation, Cardiac transplantation, Cardiogenic, Cardiography, Cardiologist, Cardiology, Cardiomyocyte, Cardiomyocytes, Cardiomyopathy, Cardiopulmonary, Cardiovascular, Cardiovascular disease, Cardiovascular mortality, Cardioversion, Carvedilol, Caspase, Catheterization, Cerivastatin, Cgmp, Chest pain, Chronic heart failure, Chronotropic, Chronotropic incompetence, Cleveland clinic foundation, Clinical characteristics, Clinical outcomes, Cohort, Concomitant, Conductance, Congestive, Congestive heart failure, Consecutive patients, Contractile, Contractility, Contraindication, Control group, Coronary, Coronary arteries, Coronary artery, Coronary artery disease, Coronary disease, Creatinine, Ctnl, Ctnt, Cytochrome, Cytokine, Daniela, Database, Decompensated, Defibrillator, Diastolic, Diastolic dysfunction, Diastolic function, Diastolic heart failure, Digoxin, Dipyridamole, Distensibility, Diuretic, Dmtx, Dobutamine, Doppler, Dosing, Dysfunction, Dyspnea, Echocardiogram, Echocardiographic, Echocardiography, Effusion, Ejection, Ejection fraction, Elderly patients, Elisa, Endocab, Endomyocardial, Endothelial, Endothelial dysfunction, Endothelial function, Endotoxin, Endpoint, Eotaxin, Epicardial, Epidemiology, Eprp, Erectile, Erectile dysfunction, Estrogen, Etiology, Etoh, Eulml, Exercise capacity, Exercise duration, Exercise performance, Exercise testing, Exercise tolerance, Familial hypertrophic cardiomyopathy, Family history, Family members, February, Fibrillation, First year, Fractional, Framingham, Furosemide, Gender, General population, Genotype, Germany background, Glucose, Goldstein, Guideline, Hamster, Hazard ratio, Healthy controls, Heart failure, Heart failure patients, Heart rate, Heart rate recovery, Heart transplantation, Heidi, Hemodynamic, Hemodynamics, Hemostatic, High risk, Hispanic, Hnocm, Hocm, Hypertension, Hypertensive, Hypertrophic, Hypertrophic cardiomyopathy, Hypertrophy, Hypotension, Hypoxia, Iabp, Idiopathic, Imaging, Immunoassay, Immunohistochemistry, Impairment, Impedance, Impedance cardiography, Important role, Independent predictor, Independent predictors, Inducible, Infarction, Inflammatory, Infusion, Inhibitor, Inos, Interventricular, Intracellular, Intracoronary, Intravenous, Invasive, Ischemia, Ischemic, Ischemic etiology, Isoform, Isometric, Ivnc, Jacc, Jacc february, January, Japan background, Kagoshima, Kinase, Kingdom background, Kobe, Lavpd, Lbbb, Leaflet, Leipzig, Leptin, Lifetime risk, Ligation, Lipid, Lipoprotein, Lmna, Losartan, Lower risk, Lschemia, Lschemic, Luminal, Lvdd, Lvedd, Lvedp, Lvef, Lvmi, Lvot, Lvot area, Lvotg, Lvsd, Lvwt, Lymphocyte, Macrophage, Magnesium, Mapk, Matrix, Mayo clinic, Median, Medical center, Medical therapy, Medicare, Medication, Mellitus, Metoprolol, Mibg, Microvascular, Mismatch, Missense, Mitral, Mitral regurgitation, Mlikglmin, Mmhg, Mmps, Monotherapy, Morbidity, Mortality, Mrna, Multivariate, Multivariate analysis, Murine, Mutation, Myocardial, Myocardial infarction, Myocarditis, Myocardium, Myocyte, Myocytes, Myosin, Natriuretic, Natriuretic peptides, Nesiritide, Neurohormonal, Neurohormone, Neurohumoral, Nicm, Nitric, Nitric oxide, Noninfarcted, Nonischemic, Norepinephrine, Normal subjects, Normalization, Nsrt, Nyha, Nyha class, Obese, Obstruction, Obstructive, Odds ratio, Oool, Orange county convention center, Outpatient, Oxidative, Oxidative stress, Oxldl, Paolo, Paroxysmal, Pathophysiology, Pathway, Patient, Patlents, Patrents, Pbmc, Pcp, Pcwp, Peak exercise, Peak oxygen consumption, Peptide, Percutaneous, Perfusion, Pericardial, Pericarditis, Pgiml, Phenotype, Piiinp, Placebo, Placebo group, Plasma concentrations, Plasma levels, Polymorphism, Posttransplant, Pred, Predictor, Present study, Presentation hour, Prevalence, Previous studies, Primary care, Proanp, Procollagen, Prog, Prognosis, Prognostic, Prognostic value, Progression, Proinflammatory, Provider, Pseudonormal, Ptsma, Pulse pressure, Pylorus, Quartile, Radioimmunoassay, Randomised, Randomized, Range years, Ranolazine, Readmission, Receptor, Receptor blockade, Regurgitation, Rehab, Renal, Renal function, Renin, Reperfusion, Revascularization, Risk factors, Risk stratification, Roche, Ryr2, Sauna, Segment depression, Septal, Septum, Severe heart failure, Sham, Sharma, Significant change, Significant difference, Significant differences, Significant improvement, Significant increase, Significant reduction, Simple score, Sinus, Sinus rhythm, Spillover, Spironolactone, Stenosis, Stenting, Steven, Stroke volume, Subgroup, Subset, Substudy, Sudden death, Superoxide, Syncope, Synthase, Systolic, Systolic blood pressure, Systolic dysfunction, Systolic function, Tachycardia, Takashi, Tamponade, Tetrahydrobiopterin, Tgfbl, Thalassemia, Therapy, Tnfa, Total mortality, Trabeculation, Trandolapril, Transduction, Transmitral, Transplant, Transplantation, Transthoracic, Treadmill, Troponin, Txcad, Ultrasound, Univariate, Univariate analysis, Unselected, Upregulated, Valvular, Vasc, Vasculopathy, Vasodilation, Vasomotor, Vasorelaxation, Vegf, Venous, Ventricular, Ventricular dysfunction, Ventricular ejection fraction, Ventricular function, Ventricular hypertrophy, Ventricular systolic dysfunction, Ventricular systolic function, Ventricular tachycardia, Vital capacity, Vsmc, Wall stress, Wall thickness, Wang, Ware, Workload, Wrth.

Url:

• https://api.istex.fr/ark:/67375/6H6-GC3J1FCB-Q/fulltext.pdf

DOI: 10.1016/S0735-1097(01)80003-6

---

Links to Exploration step

ISTEX:945CBB5E1AA287E2E692FEDCFEFB96C006306D15

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002265 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002265 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    InforLorV4
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:945CBB5E1AA287E2E692FEDCFEFB96C006306D15
   |texte=   Cardiac function and heart failure
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Jun 10 21:56:28 2019. Site generation: Fri Feb 25 15:29:27 2022